Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

876
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
876
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

548
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
548
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

175
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
175
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

357
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
357
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

386
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
386
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

56
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
56

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conversion of a Stand-Alone Academic Ambulatory Surgical Center into an Intensive Care Unit During the COVID-19 Pandemic in New York City: Challenges and Lessons Learned.

Disaster medicine and public health preparedness·2026
Same author

Neurologic Emergencies.

Emergency medicine clinics of North America·2025
Same author

Neurologic Specific Risk: Strokes, Lytics, and Litigation.

Emergency medicine clinics of North America·2024
Same author

Ethical Decision-making Using Trauma-Informed Principles: A Case Example.

AACN advanced critical care·2024
Same author

A rapid host-protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy study.

Journal of the American College of Emergency Physicians open·2024
Same author

Efficacy and tolerability of oral morphine versus oxycodone/acetaminophen for analgesia in the emergency department.

Journal of opioid management·2023

Related Experiment Video

Updated: Aug 6, 2025

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
12:41

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat

Published on: August 28, 2021

4.4K

Droperidol Use in the Emergency Department: A Clinical Review.

Rebecca B Siegel1, Sergey M Motov2, Evie G Marcolini3

  • 1Department of Emergency Medicine, Brookdale University Hospital Medical Center, Brooklyn, New York.

The Journal of Emergency Medicine
|March 16, 2023
PubMed
Summary

Droperidol is an effective medication for sedation, nausea, and pain relief, even with past safety concerns. It offers benefits in psychosis, migraines, and post-operative care, proving safe and effective.

Keywords:
analgesicantiemeticanxiolyticboxed warningdroperidolneuroleptanalgesia

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.6K
Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.5K

Related Experiment Videos

Last Updated: Aug 6, 2025

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
12:41

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat

Published on: August 28, 2021

4.4K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.6K
Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.5K

Area of Science:

  • Pharmacology
  • Clinical Medicine

Background:

  • Droperidol, a butyrophenone, possesses antiemetic, sedative, anxiolytic, and analgesic properties.
  • Its clinical use diminished following a 2001 FDA boxed warning regarding safety concerns.

Approach:

  • This clinical review provides evidence-based answers regarding droperidol's safety and efficacy.
  • Examines droperidol's effectiveness across various clinical indications.

Key Points:

  • Droperidol demonstrates superior sedative efficacy and faster onset compared to haloperidol in acute psychosis.
  • It is equally or more effective than ondansetron and metoclopramide as an antiemetic, with opioid-sparing effects.
  • Effective for migraines and as an adjunct for opioid-tolerant patients with abdominal pain.

Conclusions:

  • Droperidol is effective and safe, despite FDA warnings.
  • It serves as a potent antiemetic, sedative, anxiolytic, antimigraine agent, and analgesic adjunct.
  • Routine ECG screening is not necessary for low-dose droperidol in healthy patients in the ED.